160959 Older adult admissions to substance abuse treatment: Findings from the Treatment Episode Data Set

Tuesday, November 6, 2007: 9:30 AM

Deborah H. Trunzo, BA , Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Rockville, MD
Leigh H. Henderson, PhD , Synectics for Management Decisions, Inc., Arlington, VA
While the vast majority of admissions to substance abuse treatment are under the age of 50, older adults represent a growing segment of the treatment population. With the aging of the “baby-boom” generation, the size of this treatment cohort is expected to increase in coming years, placing new demands on the substance abuse treatment system. Using data from the Treatment Episode Data Set (TEDS), this paper will examine trends and characteristics of admissions for adults 50 and over, focusing on substances of abuse and drug use history, client demographic and socioeconomic characteristics, treatment service setting, sources of referral, length of stay in treatment and disposition at discharge. Analyses will include TEDS data from 1992 through 2005. TEDS is a compilation of data on the approximately 1.8 million annual admissions to substance abuse treatment, primarily admissions at facilities that receive some public funding.

This presentation is part of the session titled Using Population and Facility Data to Understand Emerging Substance Abuse and Mental Health Phenomena: New Findings from SAMHSA's Office of Applied Studies, chaired by Anna Marsh.

Learning Objectives:
1. Identify the proportion of treatment admissions attributable to persons age 50 and older 2. Describe the substance abuse and demographic characteristics of treatment admissions aged 50 and over. 3. Evaluate the implications of trends in treatment admissions aged 50 and over

Keywords: Substance Abuse Treatment, Aging

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.